Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3320
Selected: 0
NCT IDTitle
NCT07917832Smart 3: A Multi-Center Phase 2 Trial Of Golcadomide, Glofitamab And Polatuzumab Vedotin (G2P) For Patients With Newly Diagnosed Large B-Cell Lymphoma
NCT05327270Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions
NCT07011654Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
NCT020574453rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma
NCT00527761Taxotere/Temodar/Cisplatin Study in Melanoma Patients
NCT00050986Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
NCT04604522Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome
NCT00883688Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
NCT01750983Ipilimumab and Lenalidomide in Advanced Cancer
NCT00413166All-trans Retinoic Acid, and Arsenic +/- Idarubicin
NCT02160366Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients
NCT00423722Parenteral Hydration in Advanced Cancer Patients
NCT05046080Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
NCT05273554A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
NCT03199196Using Social Networks to Promote Physical Activity in African American and Hispanic Women
NCT02060370Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
NCT00426829Proton Therapy and Bevacizumab for Primary Liver Tumors
NCT00671827Evaluation of Robot-Assisted Surgery in Gynecologic Oncology
NCT00215202Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
NCT05744557Vapocoolant Analgesia for Breast Lymphoscintigraphy
NCT02511600Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication
NCT05041153Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
NCT06218602Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
NCT06563375Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors
NCT00610181Magnetic Resonance Imaging in Patients With Breast Cancer
NCT02203136Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
NCT00878267Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study
NCT00142571Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
NCT00493571Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
NCT06597734A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm
NCT00806507Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients
NCT07318363IGNITE-TX Phase III: (Identifying Individuals for Genetic Testing & Treatment) Intervention
NCT04668300Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma
NCT03287492RCT of QPS vs General Information Sheet
NCT00038792Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD
NCT05091632Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit
NCT00792077A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue
NCT04983901PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
NCT05048212A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
NCT04904302Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer
NCT05589857A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
NCT01811628Project Impact: A Culturally-Tailored Adherence Intervention for Latino Smokers
NCT00423436Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients
NCT02029612An Evidence Based Smoking Cessation Program for Persons Living With HIV/AIDS (Project Legacy)
NCT00505492Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy
NCT01008787Motivational Interviewing for Physical Activity
NCT01504919Reducing Cancer Disparities Among Latinos in Texas
NCT02389309Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
NCT07023432Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)
NCT00270907CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer